Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care
Other compounding pharmacies were not using the exact same form of semaglutide as the brand-name drugs, instead using cheaper research grade, food grade, and/or different salt forms
This is standard across virtually all telehealth GLP-1 providers and reflects the perishable nature of compounded medications that require refrigerated storage
For now, patients face a clear set of tradeoffs: oral convenience with approximately 15% weight loss (semaglutide or orforglipron), or injectable inconvenience with approximately 20-22% weight loss (tirzepatide)
Its important to be aware of these potential outcomes, which frequently include: Nausea Vomiting Diarrhea Abdominal pain Constipation These symptoms typically diminish over time as your body acclimates to the medication, with a median onset time for weak signals being approximately 7 days
Weve vetted four GLP-1 telehealth programs on price, refund policies, and pharmacy quality see our 2026 GLP-1 telehealth programs comparison for the side-by-side.